6533b861fe1ef96bd12c4691
RESEARCH PRODUCT
Paradoxical effect of l-arginine: Acceleration of endothelial cell senescence
Jens Martens-lobenhofferUwe LendeckelEva D.m. FlickEllen I. ClossAnke HeimburgStefanie M. Bode-bögerJean‑paul BoisselFortunato Scalerasubject
SenescenceArginineEndotheliumBiophysicsBiologyArginineNitric OxideBiochemistryNitric oxidechemistry.chemical_compoundmedicineHumansCationic Amino Acid Transporter 2Molecular BiologyCells CulturedCellular SenescenceCationic Amino Acid Transporter 1ArginaseEndothelial CellsCell BiologyTransfectionMolecular biologyArginaseEndothelial stem cellOxidative Stressmedicine.anatomical_structurechemistryEndothelium VascularPeroxynitritedescription
We have recently shown that inhibition of nitric oxide (NO) synthesis by asymmetrical dimethylarginine (ADMA) accelerated endothelial cell (EC) senescence which was prevented by coincubation with L-arginine; however the effect of long-term treatment of l-arginine alone on senescence of ECs have not been investigated. Human ECs were cultured in medium containing different concentrations of L-arginine until senescence. L-Arginine paradoxically accelerated senescence indicated by inhibiting telomerase activity. Moreover, L-arginine decreased NO metabolites, increased peroxynitrite, and 8-iso-prostaglandin F(2alpha) formation. In old cells, the mRNA expression of human amino acid transporter (hCAT)2B, the activity and protein expression of arginase II were upregulated indicated by enhanced urea, L-ornithine, and L-arginine consumption. Inhibition of arginase activity, or transfection with arginase II siRNA prevented L-arginine-accelerated senescence. The most possible explanation for the paradoxical acceleration of senescence by L-arginine so far may be the translational and posttranslational activation of arginase II.
year | journal | country | edition | language |
---|---|---|---|---|
2009-06-16 | Biochemical and Biophysical Research Communications |